Inovio Pharmaceuticals Announces Strategic Cancer Vaccine Collaboration and License Agreement With AstraZeneca's MedImmune Unit
August 10, 2015 at 04:16 AM EDT
Inovio Pharmaceuticals (Nasdaq: INO) today announced that it has entered into a license agreement and collaboration with MedImmune, the ...